![Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide - Biocon Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide - Biocon](https://www.biocon.com/wp-content/uploads/2021/02/Biocon-Biologics-Joins-Hands-with-IDF-in-its-Mission-to-Promote-Diabetes-Care-1110x630.png)
Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide - Biocon
![Biocon Biologics and Mylan Announce Launch of Semglee in the U.S. to Expand Access for Patients Living with Diabetes | World Pharma Today Biocon Biologics and Mylan Announce Launch of Semglee in the U.S. to Expand Access for Patients Living with Diabetes | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/press-releases/15044/Biocan_Mylan.jpg)
Biocon Biologics and Mylan Announce Launch of Semglee in the U.S. to Expand Access for Patients Living with Diabetes | World Pharma Today
![Biologics | Free Full-Text | Management of Invasive Infections in Diabetes Mellitus: A Comprehensive Review Biologics | Free Full-Text | Management of Invasive Infections in Diabetes Mellitus: A Comprehensive Review](https://www.mdpi.com/biologics/biologics-03-00004/article_deploy/html/images/biologics-03-00004-g001.png)
Biologics | Free Full-Text | Management of Invasive Infections in Diabetes Mellitus: A Comprehensive Review
Biocon Biologics - #Press: Biocon Biologics Collaborates with RSSDI to Expand Access to its Insulins for Children with Type 1 Diabetes on #WorldDiabetesDay, a step towards our commitment of #ExpandingUniversalAccess to global
AGC Biologics Supports Commercial Production of Provention Bio's New Type 1 Diabetes (T1D) Therapy, TZIELD™
Biocon Biologics on Twitter: ""It is a milestone achievement for both #BioconBiologics & our partner @ViatrisInc. This will allow pharmacy level substitution and thereby provide convenient and affordable access to #Semglee, a
![Frontiers | Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes Frontiers | Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes](https://www.frontiersin.org/files/MyHome%20Article%20Library/369532/369532_Thumb_400.jpg)
Frontiers | Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes
![Biocon Biologics and Voluntis introduce Insulia, an FDA-cleared, Digital Therapeutic in India - Express Healthcare Biocon Biologics and Voluntis introduce Insulia, an FDA-cleared, Digital Therapeutic in India - Express Healthcare](https://cdn.expresshealthcare.in/wp-content/uploads/2019/09/17173316/Clinivantagre-MyLife-solutions.jpg)
Biocon Biologics and Voluntis introduce Insulia, an FDA-cleared, Digital Therapeutic in India - Express Healthcare
![Biologics | Free Full-Text | Management of Invasive Infections in Diabetes Mellitus: A Comprehensive Review Biologics | Free Full-Text | Management of Invasive Infections in Diabetes Mellitus: A Comprehensive Review](https://pub.mdpi-res.com/biologics/biologics-03-00004/article_deploy/html/images/biologics-03-00004-ag.png?1678264463)